Table 1.
Socio-Demographic Characteristics of Study Participants
| Characteristics | Cancer group (n = 19) | Control group (n = 19) | P |
|---|---|---|---|
| Age (years) | 61.46 ± 8.79 | 57.62 ± 7.57 | 0.301 |
| Body mass index | 28.36 ± 4.94 | 28.06 ± 3.74 | 0.844 |
| Sex | |||
| Male (%) | 15.79 (n = 3) | 26.32 (n = 5) | 0.426 |
| Female (%) | 84.21 (n = 16) | 73.68 (n = 14) | |
| Cancer diagnosis (months) | 49.78 ± 39.40 | ||
| Performs physical activity (%) | 26.32 (n = 5) | 31.58 (n = 6) | 0.721 |
| Smoking (%) | 0 | 10.52 (n = 2) | |
| Alcoholism (%) | 0 | 5.26 (n = 1) | |
| Cancer diagnosis site (%) | |||
| Gastrointestinal tract | 10.52 (n = 2) | ||
| Breast | 47.37 (n = 9) | ||
| Abdomino-pelvic | 5.26 (n = 1) | ||
| Ovary | 10.52 (n = 2) | ||
| Uterus | 10.52 (n = 2) | ||
| Prostate | 10.52 (n = 2) | ||
| Oropharynx | 10.52 (n = 2) | ||
| Stage (%) | |||
| 0 | 0 | ||
| I | 15.79 (n = 3) | ||
| II | 47.37 (n = 9) | ||
| III | 10.52 (n = 2) | ||
| IV | 0 | ||
| No data | 26.32 (n = 5) | ||
| Chemotherapeutic drug (%) | |||
| Antibiotics | 11.1 (n = 1) | ||
| Platinum | 22.2 (n = 2) | ||
| Taxanes | 66.7 (n = 6) | ||
| Types of treatment performed (%) | |||
| Just surgery | 5.26 (n = 1) | ||
| Just chemotherapy | 0 | ||
| Just radiotherapy | 10.52 (n = 2) | ||
| Surgery and chemotherapy | 21.05 (n = 4) | ||
| Surgery and radiotherapy | 5.26 (n = 1) | ||
| Chemotherapy and radiotherapy | 5.26 (n = 1) | ||
| All | 52.65 (n = 10) | ||
Mean ± standard deviation; %, percentages; n, number of members.